2-tert-Butyloxycarbonylaminomethyl-5-phenyl-[1,3,4]oxadiazole, 95.0%, 1g

4-Methyltetrahydro-2H-pyran-4-carbaldehyde, 95.0%, 10g

3-(4-Fluoro-phenylsulfanylmethyl)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

2,7-Dibromo-9,9-diphenylfluorene>98.0%(GC)1g

Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate, 95.0%, 5g

5-amino-1-cyclopentyl-2,3-dihydro-1H-pyrazol-3-one, 95+%, 100mg

2-(4-METHOXYPHENYL)-2-MORPHOLIN-4-YLETHYLAMINE 2HCL, 95.0%, 1g

(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol, 95.0%, 5g

Ethyl 5-bromo-2-chloropyrimidine-4-carboxylate, 95+%, 250mg

Sample tub with snap-on lid, 5 ml, 25 Piece(s)

3,3',5,5'-Tetra-tert-butyl-[1,1'-biphenyl]-2,2'-diol, 98.0%, 5g

6-Cyclobutoxypyridin-3-amine, 98%, 100mg

GC capillary column ROTI®Cap-5, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)